Since Gal-1 is considered as a pro-tumorigenic galectin [30], we anticipated a mutually exclusive expression with respect to Gal-7 as an indication of positive clinical outcome in cervical cancer. This evidence concerns the gene LGALS7 and cervical carcinoma.